Subscribe To
MacroGenics Announces Date of Fourth Quarter 2022 Financial Results Conference Call
ROCKVILLE, MD, March 07, 2023 (GLOBE NEWSWIRE) — MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing and commercializing innovative monoclonal antibody-based therapeutics for the treatment of cancer, today announced that the Company will release its financial results for the fourth quarter of 2022 after the market closes on Wednesday, March 15, 2023. MacroGenics […] The post MacroGenics Announces Date of Fourth Quarter 2022 Financial Results Conference Call appe...
Read More
Posted: Mar 7 2023, 23:00
Author Name: forextv
Views: 103162